TY - GEN A1 - Keller, Jürgen A1 - Gorges, Martin A1 - Aho-Özhan, Helena Eira Anneli A1 - Carmona, S. A1 - Schneider, Erich T1 - Eye-tracking control to assess cognitive functions in patients with amyotrophic lateral sclerosis T2 - JoVE Y1 - 2016 U6 - https://doi.org/10.3791/54634 SN - 1940-087X VL - 116 SP - e54634 ER - TY - GEN A1 - Donald, Aimee A1 - Tan, Chong Y. A1 - Chakrapani, Anupam A1 - Hughes, Derralyn A. A1 - Sharma, Reena A1 - Cole, Duncan A1 - Bardins, Stanislav A1 - Gorges, Martin A1 - Jones, Simon A. A1 - Schneider, Erich T1 - Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease T2 - Orphanet journal of rare diseases : OJRD N2 - Background: Neurological forms of Gaucher disease, the inherited disorder of β-Glucosylceramidase caused by bi-allelic variants in GBA1, is a progressive disorder which lacks a disease-modifying therapy. Systemic manifestations of disease are effectively treated with enzyme replacement therapy, however, molecules which cross the blood-brain barrier are still under investigation. Clinical trials of such therapeutics require robust, reproducible clinical endpoints to demonstrate efficacy and clear phenotypic definitions to identify suitable patients for inclusion in trials. The single consistent clinical feature in all patients with neuronopathic disease is the presence of a supranuclear saccadic gaze palsy, in the presence of Gaucher disease this finding serves as diagnostic of 'type 3' Gaucher disease. Y1 - 2020 UR - https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01637-9 U6 - https://doi.org/10.1186/s13023-020-01637-9 SN - 1750-1172 VL - 15 ER - TY - GEN A1 - Nanning, Felix A1 - Braune, Katharina A1 - Uttner, Ingo A1 - Ludolph, Albert Christian A1 - Gorges, Martin A1 - Lulé, Dorothée T1 - Altered Gaze Control During Emotional Face Exploration in Patients With Amyotrophic Lateral Sclerosis T2 - Neurology N2 - Objectives Up to 50% of patients with amyotrophic lateral sclerosis (ALS) present with cognitive problems and behavioral dysfunctions including recognition of human faces presenting different emotions. We investigated whether impaired processing of emotional faces is associated with abnormal scan paths during visual exploration. Methods Cognitively unimpaired patients with ALS (n = 45) and matched healthy controls (n = 37) underwent neuropsychological assessment and video-based eye tracking. Eye movements were recorded while participants visually explored faces expressing different emotions (neutral, disgusted, happy, fearful, and sad) and houses mimicking faces. Results Compared with controls, patients with ALS fixated significantly longer to regions which are not relevant for emotional information when faces expressed fear (p = 0.007) and disgust (p = 0.006), whereas the eyes received less attention in faces expressing disgust (p = 0.041). Fixation duration in any area of interest was not significantly associated with the cognitive state or clinical symptoms of disease severity. Discussion In cognitively unimpaired patients with ALS, altered gaze patterns while visually exploring faces expressing different emotions might derive from impaired top-down attentional control with possible involvement of subliminal frontotemporal areas. This may account for indistinctness in emotion recognition reported in previous studies because nonsalient features retrieve more attention compared with salient areas. Current findings may indicate distinct emotion processing dysfunction of ALS pathology, which may be different from, for example, executive dysfunction. KW - Amyotrophic lateral sclerosis KW - Clinical Neurology KW - Clinical neurology examination KW - Neuro-ophthalmology KW - Neuromuscular Disease KW - Visual processing Y1 - 2023 U6 - https://doi.org/10.1212/WNL.0000000000207214 SN - 0028-3878 VL - 101 IS - 6 SP - 264 EP - 269 ER - TY - GEN A1 - Charissé, Daniel A1 - Erus, Guray A1 - Pomponio, Raymond A1 - Gorges, Martin A1 - Schmidt, Nele A1 - Schneider, Christine A1 - Liepelt-Scarfone, Inga A1 - Riedel, Oliver A1 - Reetz, Kathrin A1 - Schulz, Jörg B. A1 - Berg, Daniela A1 - Storch, Alexander A1 - Witt, Karsten A1 - Dodel, Richard A1 - Kalbe, Elke A1 - Kassubek, Jan A1 - Hilker-Roggendorf, Rüdiger A1 - Baudrexel, Simon T1 - Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease T2 - Neurobiology of Aging N2 - Recently, it was shown that patients with Parkinson's disease (PD) who exhibit an “Alzheimer's disease (AD)-like” pattern of brain atrophy are at greater risk for future cognitive decline. This study aimed to investigate whether this association is domain-specific and whether atrophy associated with brain aging also relates to cognitive impairment in PD. SPARE-AD, an MRI index capturing AD-like atrophy, and atrophy-based estimates of brain age were computed from longitudinal structural imaging data of 178 PD patients and 84 healthy subjects from the LANDSCAPE cohort. All patients underwent an extensive neuropsychological test battery. Patients diagnosed with mild cognitive impairment or dementia were found to have higher SPARE-AD scores as compared to patients with normal cognition and healthy controls. All patient groups showed increased brain age. SPARE-AD predicted impairment in memory, language and executive functions, whereas advanced brain age was associated with deficits in attention and working memory. Data suggest that SPARE-AD and brain age are differentially related to domain-specific cognitive decline in PD. The underlying pathomechanisms remain to be determined. KW - Alzheimer's disease KW - Brain Age KW - MRI KW - Parkinson's disease KW - Pattern classification Y1 - 2022 UR - https://www.sciencedirect.com/science/article/pii/S0197458021002748?via%3Dihub U6 - https://doi.org/10.1016/j.neurobiolaging.2021.08.020 SN - 0197-4580 VL - 109 SP - 31 EP - 42 ER - TY - GEN A1 - Ramaioli, Cecilia A1 - Steinmetzer, Tobias A1 - Brietzke, Adrian A1 - Meyer, Paul A1 - Pham Xuan, Rebecca A1 - Schneider, Erich A1 - Gorges, Martin T1 - Assessment of vestibulo-ocular reflex and its adaptation during stop-and-go car rides in motion sickness susceptible passengers T2 - Experimental Brain Research N2 - Motion sickness is a physiological condition that negatively impacts a person's comfort and will be an emerging condition in autonomous vehicles without proper countermeasures. The vestibular system plays a key role in the origin of motion sickness. Understanding the susceptibility and (mal) adaptive mechanisms of the highly integrated vestibular system is a prerequisite for the development of countermeasures. We hypothesize a differential association between motion sickness and vestibular function in healthy individuals with and without susceptibility for motion sickness. We quantified vestibular function by measuring the high-frequency vestibulo-ocular reflex (VOR) using video head impulse testing (vHIT) in 17 healthy volunteers before and after a 11 min motion sickness-inducing naturalistic stop-and-go car ride on a test track (Dekra Test Oval, Klettwitz, Germany). The cohort was classified as motion sickness susceptible (n = 11) and non-susceptible (n = 6). Six (out of 11) susceptible participants developed nausea symptoms, while a total of nine participants were free of these symptoms. The VOR gain (1) did not differ significantly between participant groups with (n = 8) and without motion sickness symptoms (n = 9), (2) did not differ significantly in the factor time before and after the car ride, and showed no interaction between symptom groups and time, as indicated by a repeated measures ANOVA (F(1,15) = 2.19, p = 0.16. Bayesian inference confirmed that there was “anecdotal evidence” for equality of gain rather than difference across groups and time (BF10 < 0.77). Our results suggest that individual differences in VOR measures or adaptation to motion sickness provocative stimuli during naturalistic stop-and-go driving cannot predict motion sickness susceptibility or the likelihood of developing motion sickness. KW - Video head impulse test KW - Vestibulo-ocular reflex KW - Adaptation KW - Motion sickness KW - Stop-and-go car ride Y1 - 2023 U6 - https://doi.org/10.1007/s00221-023-06619-4 SN - 1432-1106 SN - 0014-4819 VL - 241 IS - 6 SP - 1523 EP - 1531 ER -